Increased retinoic acid receptor-β4 correlates in vivo with reduced retinoic acid receptor-β2 in esophageal squamous cell carcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 4, 2005, Pages 826-829

  Xu, Xiao Chun ^a   Lee, J Jack ^a   Wu, Tsung Teh ^a   Hoque, Ashraful ^a   Ajani, Jeffer A ^a   Lippman, Scott M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR BETA2; RETINOIC ACID RECEPTOR BETA4; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ESOPHAGUS; ESOPHAGUS CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEIN ISOFORMS; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 16444379652     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0500     Document Type: Article

References (39)

1. Posner MC, editor. Cancer of the upper gastrointestinal tract. Atlanta (GA): American Cancer Society; 2002. p. 1-22, 47-66, 67-84.
2. DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. Philadelphia and New York: Lippincott-Raven Publishers; 1997. p. 231-58, 585-608, 980-1020.
3. Richter JE. Esophagus. In: Brandt LJ, editor. Clinical practice of gastroenterology, vol 1. Philadelphia: Churchill Livingstone; 1999. p. 1-150.
4. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
5. Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997;89:1277-84.
6. McCann J. Esophageal cancers: changing character, increasing incidence. J Natl Cancer Inst 1999;91:497-8.
7. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-6.
8. Kim R, Weissfeld JL, Reynolds JC, Kuller LH. Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 1997;6:369-77.
9. Spechler SJ. Barrett's esophagus. Semin Oncol 1994;21:431-7.
10. Bolt WJ, Devesa SS, Kneller RW. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
11. Menke-Pluymers MBE. Risk factors for neoplastic progression in Barrett's mucosa. Eur J Surg Oncol 1996;22:311-6.
12. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R. Expression and upregulation of retinoic acid receptor-β is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 1999;59:2477-83.
13. Qiu H, Zhang W, El-Naggar AK, et al. Loss of retinoic acid receptor-β expression is an early event during esophageal carcinogenesis. Am J Pathol 1999;155:1519-23.
14. Zhang W, Rashid A, Wu H, Xu XC. Differential expression of retinoic acid receptors and p53 protein in normal, premalignant, and malignant esophageal tissues. J Cancer Res Clin Oncol 2001;127:237-42.
15. Kuroki T, Trapasso F, Yendamuri S, et al. Allele loss and promoter hypermethylation of VHL, RAR-β, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 2003;63:3724-8.
16. Su H, Hu N, Shih J, et al. Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res 2003;63:3872-6.
17. Xu M, Jin YL, Fu J, et al. The abnormal expression of retinoic acid receptor-β, p53 and Ki67 protein in normal, premalignant and malignant esophageal tissues. World J Gastroenterol 2002;8:200-2.
18. Wang Y, Fang MZ, Liao J, et al. Hypermethylation-associated inactivation of retinoic acid receptor β in human esophageal squamous cell carcinoma. Clin Cancer Res 2003;9:5257-63.
19. Fang MZ, Wang Y, Ai N, et al. Tea polyphenol (-)-epigallocatechin-3- gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003;63:7563-70.
20. Liu ZM, Ding F, Guo MZ, Zhang LY, Wu M, Liu ZH. Downregulation of retinoic acid receptor-β(2) expression is linked to aberrant methylation in esophageal squamous cell carcinoma cell lines. World J Gastroenterol 2004;10:771-5.
21. Li M, Song S, Lippman SM, et al. Induction of retinoic acid receptor-β suppresses cyclooxygenase-2 expression in esophageal cancer cells. Oncogene 2002;21:411-8.
22. Song S, Xu XC. Effect of benzo(a)pyrene diol epoxide on expression of retinoic acid receptor-β in immortalized esophageal epithelial cells and esophageal cancer cells. Biochem Biophys Res Commun 2001;281:872-7.
23. Zelent A, Mendelsohn C, Kastner P, et al. Differentially expressed isoforms of the mouse retinoic acid receptor β generated by usage of two promoters and alternative splicing. EMBO J 1991;10:71-81.
24. Toulouse A, Morin J, Pelletier M, Bradley WEC. Structure of the human retinoic acid receptor-β1 gene. Biochim Biophys Acta 1996;1309:1-4.
25. Houle B, Pelletier M, Wu J, Goodyer C, Bradley WE. Fetal isoform of human retinoic acid receptor β expressed in small cell lung cancer lines. Cancer Res 1994;54:365-9.
26. Berard J, Delabre JF, Garneau H, Bellehumeur C, Carrier ME. Lung tumorigenesis in transgenic mice expressing RAR-β1 and RAR-β3 antisense mRNA. Lung Cancer 2003;41:S122.
27. Xu XC, Lotan R. Aberrant expression and function of retinoid receptors in cancer. In: Nau H, Blaner WS, editors. Handbook of experimental pharmacology Berlin and New York: Springer Verlag; 1999. p. 323-43.
28. 2 by alternative splicing and usage of a CUG initiator codon. Proc Natl Acad Sci U S A 1992;89:2718-22.
29. Sommer KM, Chen LI, Treuting PM, Smith LT, Swisshelm K. Elevated retinoic acid receptor β(4) protein in human breast tumor cells with nuclear and cytoplasmic localization. Proc Natl Acad Sci U S A 1999;96:8651-6.
30. 4-like transgene. EMBO J 1994;13:5570-80.
31. Hayashi K, Goodison S, Urquidi V, Tarin D, Lotan R, Tahara E. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor β isoforms 2 and 4. Int J Oncol 2003;22:623-9.
32. Lin B, Chen GQ, Xiao D, et al. Orphan receptor COUP-TF is required for induction of retinoic acid receptor β, growth inhibition, and apoptosis by retinoic acid in cancer cells. Mol Cell Biol 2000;20:957-70.
33. Wu Q, Li Y, Liu R, et al. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J 1997;16:1656-69.
34. Dragnev KH, Petty WJ, Dmitrovsky E. Retinoid targets in cancer therapy and chemoprevention. Cancer Biol Ther 2003;2:S150-6.
35. James SY, Lin F, Kolluri SK, Dawson MI, Zhang XK. Regulation of retinoic acid receptor β expression by peroxisome proliferator-activated receptor γ ligands in cancer cells. Cancer Res 2003;63:3531-8.
36. Berry DA, editor. Statistical methodology in the pharmaceutical sciences. New York: Marcel Dekker; 1989.
37. Zhou C, Tsai SY, Tsai M. From apoptosis to angiogenesis: new insights into the roles of nuclear orphan receptors, chicken ovalbumin upstream promoter-transcription factors, during development. Biochim Biophys Acta 2000;1470:M63-8.
38. Terashita Y, Sasaki H, Haruki N, et al. Decreased peroxisome proliferator-activated receptor γ gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol 2002;32:238-43.
39. Fujii D, Yoshida K, Tanabe K, Hihara J, Toge T. The ligands of peroxisome proliferator-activated receptor (PPAR) γ inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest. Anticancer Res 2004;24:1409-16.